InvestorsHub Logo

DewDiligence

11/01/10 1:18 PM

#107683 RE: JJM760 #107682

Then could you expound on a theory as to why He handled (and phrased) the dilution as he did?

I didn’t realize ARIA’s financings were subject to divine intervention :- )

Seriously, I’m not clear on what question you’re asking. Is it simply about the timing of the financing deal?

poorgradstudent

11/01/10 1:54 PM

#107693 RE: JJM760 #107682

ARIA:

You take the money while you can.

Berger basically sold stock at a 3 year high to fund the development of his best drug.

If he had waited for the rida results, a negative outcome could have disproportionately cratered his stock, leaving him to dilute at lower levels.

No conspiracy. It's just what the CEO has to do to keep afloat a money-losing biotech.

rkrw

11/01/10 2:07 PM

#107696 RE: JJM760 #107682

A good ceo should have a long term plan and not just stage events around the interest of short term shareholders who care most about the immediate stock price.

The tactical decision they seem to have made is to retain as much of 534 as they can, in particular, US rights. That takes money.

It seems you want to have both ways with Ariad and the CEO. Raise money now, how awful of him diluting shareholders. Roll the dice on Rida and raise after the data, if it happens to fail, then it will be why didn't he raise money before the data?